ConductScience.org, home

Paper38005258

Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.

Marras E and 12 others. Molecules, 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights. Papers, record 38005258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38005258

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ruthenium(II)-Arene Curcuminoid Complexes as Photosensitizer Agents for Antineoplastic and Antimicrobial Photodynamic Therapy: In Vitro and In Vivo Insights.
PubMed
Journal
Molecules
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.21
iCite
Revised in PubMed
2023-11-27
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Marras EEmanuela
2Balacchi CJCamilla J
3Orlandi VVivianahttps://orcid.org/0000-0001-6010-2840
4Caruso EEnricohttps://orcid.org/0000-0002-6700-911X
5Brivio MFMaurizio Fhttps://orcid.org/0000-0002-1002-0422
6Bolognese FFabrizio
7Mastore MMaristellahttps://orcid.org/0000-0003-0514-521X
8Malacarne MCMiryam Chttps://orcid.org/0000-0002-3779-7231
9Rossi MMiriamhttps://orcid.org/0000-0001-9609-474X
10Caruso FFrancesco
11Vivona VVeronicahttps://orcid.org/0009-0002-5978-0243
12Ferrario NNicolehttps://orcid.org/0009-0007-0170-3671
13Gariboldi MBMarzia Bhttps://orcid.org/0000-0002-5683-0885

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RutheniumMajor topic
CurcuminMajor topic
Coordination ComplexesMajor topic
Antineoplastic AgentsMajor topic
PhotochemotherapyMajor topic
Humans
Photosensitizing Agents
Diarylheptanoids
Anti-Bacterial Agents

Source PubMed

Download CSV of topics

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132162523Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.J Nat Prod2020https://conductscience.org/library/papers/32162523PubMed
234769259Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents.Int J Mol Sci2021https://conductscience.org/library/papers/34769259PubMed
336978373The Virtuous Galleria mellonella Model for Scientific Experimentation.Antibiotics (Basel)2023https://conductscience.org/library/papers/36978373PubMed
425544762Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling.Oncotarget2015https://conductscience.org/library/papers/25544762PubMed
536839961Curcumin a Natural Phenol and Its Therapeutic Role in Cancer and Photodynamic Therapy: A Review.Pharmaceutics2023https://conductscience.org/library/papers/36839961PubMed
621665453Photodynamic activity of anthraquinones isolated from Heterophyllaea pustulata Hook f. (Rubiaceae) on MCF-7c3 breast cancer cells.Phytomedicine2011https://conductscience.org/library/papers/21665453PubMed
727293144The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.J Inorg Biochem2016https://conductscience.org/library/papers/27293144PubMed
825344453Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.Invest New Drugs2015https://conductscience.org/library/papers/25344453PubMed
930023938Targeting of a Photosensitizer to the Mitochondrion Enhances the Potency of Photodynamic Therapy.ACS Omega2018https://conductscience.org/library/papers/30023938PubMed
1031137659NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry.Molecules2019https://conductscience.org/library/papers/31137659PubMed
1126158541Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.Acc Chem Res2015https://conductscience.org/library/papers/26158541PubMed
1219855190Assessing autophagy in the context of photodynamic therapy.Autophagy2010https://conductscience.org/library/papers/19855190PubMed
1331096157Porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria.Eur J Med Chem2019https://conductscience.org/library/papers/31096157PubMed
1433915370BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT.Eur J Med Chem2021https://conductscience.org/library/papers/33915370PubMed
1534093012Combination of Chemotherapy and Photodynamic Therapy with Oxygen Self-Supply in the Form of Mutual Assistance for Cancer Therapy.Int J Nanomedicine2021https://conductscience.org/library/papers/34093012PubMed
1620965744Antibacterial activity of anthraquinone derivatives from Heterophyllaea pustulata (Rubiaceae).J Photochem Photobiol B2011https://conductscience.org/library/papers/20965744PubMed
1733572457Curcumin as Scaffold for Drug Discovery against Neurodegenerative Diseases.Biomedicines2021https://conductscience.org/library/papers/33572457PubMed
1835004350Galleria mellonella as a Suitable Model of Bacterial Infection: Past, Present and Future.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/35004350PubMed
1923993858Photodynamic potential of curcumin and blue LED against Streptococcus mutans in a planktonic culture.Photodiagnosis Photodyn Ther2013https://conductscience.org/library/papers/23993858PubMed
2026202022p53 family members - important messengers in cell death signaling in photodynamic therapy of cancer?Photochem Photobiol Sci2015https://conductscience.org/library/papers/26202022PubMed

See all 72 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42737488Coumarin and Curcumin-Metal Complexes as Next-Generation Photosensitizers in Cancer Photodynamic Therapy.Int J Mol Sci2026https://conductscience.org/library/papers/42737488PubMed
39771502Toxicological Assessment of 2-Hydroxychalcone-Mediated Photodynamic Therapy: Comparative In Vitro and In Vivo Approaches.Pharmaceutics2024https://conductscience.org/library/papers/39771502PubMed
39496731Histidine containing dipeptides protect epithelial and endothelial cell barriers from methylglyoxal induced injury.Sci Rep2024https://conductscience.org/library/papers/39496731PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MAP1LC3A84557PubTator's text mininghttps://conductscience.org/library/genes/84557NCBI Gene
RNASE16035PubTator's text mininghttps://conductscience.org/library/genes/6035NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38005258

GET https://conductscience.org/api/papers/v1/38005258/references?page=2